Back to newsAnnexon target price raised to $25 from $14AANNX•2026-10-19H.C. Wainwright raised its target price for Annexon to $25 from $14.Related NewsAAtyr Pharma announces research collaboration with Montefiore EinsteinATYR•2026-10-19AAxcelis Technologies target price cut to $165 from $198ACLS•2026-10-19AAbivax shares fall after rival drug data, trader saysABVX•2026-10-19VValero Energy target price raised to $530 from $450VLO•2026-10-19IImmunic expects funding to last into late 2027IMUX•2026-10-19